CHARACTERIZATION OF A HUMAN OSTEOCLAST-LIKE CELL LINE
人类破骨细胞样细胞系的表征
基本信息
- 批准号:3157306
- 负责人:
- 金额:$ 8.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-20 至 1988-08-31
- 项目状态:已结题
- 来源:
- 关键词:1,25 dihydroxycholecalciferol affinity chromatography azacitidine biological models calcitonin cell bank /registry cell differentiation colony stimulating factor cytogenetics gene expression genetic strain hormone regulation /control mechanism monoclonal antibody osteoblasts osteoclast activating factor osteoclasts osteosarcoma parathyroid hormones physiologic bone resorption retinoate
项目摘要
Much information has been learned about the osteoblast through the use of
several cloned osteosarcoma cell lines which have the osteoblast phenotype
and have provided convenient models of osteoblast behavior and function.
No such cell line has been available as a model for the osteoclast. In
part, this may be because the mature osteoclast is a terminal cell which
does not proliferate. I have cloned a novel non-tumor forming cell line
(FM-2) with osteolytic properties from a human osteosarcoma. Phenotypic
characterization of this cell line as expressed in their ultrastructure,
enzyme contents, multinucleation, calcitonin receptors (see Appendix)
suggests that it is either an osteoclast precursor or a unique bone
resorbing cell. The formation of spleen colony forming units when infused
into irradiated rats and the phenotypic modulations shown by this cell when
grown on three-dimensional collagen lattices further suggest that it may be
an osteoclast "stem cell". The overall objective of this research proposal
is to determine if it is a cell in the osteoclast lineage, to further
characterize the osteoclastic properties of the FM-2 cell line and to
define the conditions which permit maximal expression of these
osteoclast-like properties.
The experimental protocol is designed to: 1) identify and optimize the
culture and substrate conditions which are critical for differentiation of
the FM-2 cell line. This will be achieved by culturing the cells on
devitalized bone or reconstituted substrates which may resemble bone or in
an isolated in vivo system, the atriocular space of nude mice. A
morphologic and biochemical profile to monitor phenotypic changes in the
line or new sublines will be developed, 2) determine the effects of
hormones active in bone (e.g., parathyroid hormone, calcitonin, or
1,25(OH)2D3) and differentiation factors (e.g., colony stimulating factor,
OAF, 5-azacytidine, retinoic acid) on the phenotypic expression of the cell
line, 3) restore bone remodeling function to microphthalmic mice by FM-2
cell grafts, 4) isolate and partially purify the bone resorbing factor
using hydroxyapatite chromatography. The partially purified factor will be
used to generate monoclonal antibodies for subsequent use in affinity
chromatography and studies of the biological properties of the factor.
These studies should provide new information on the differentiation of bone
resorbing stem cells in vitro. The establishment of differentiated bone
resorbing cells may prove useful as modes for understanding the biology and
biochemistry of osteoclasts and other bone resorbing cells. Such models
could also be applied to investigations of the mechanisms of bone loss in
both physiologic and pathologic states.
许多关于成骨细胞的信息是通过使用
几个克隆的具有成骨细胞表型的骨肉瘤细胞系
并提供了成骨细胞行为和功能的方便模型。
没有这样的细胞系可用作破骨细胞的模型。 在
这可能是因为成熟的破骨细胞是一种终末细胞,
不会扩散。 我克隆了一种新的非肿瘤形成细胞系
(FM-2)具有溶骨特性。 表型
该细胞系的超微结构表征,
酶含量、多核化、降钙素受体(见附录)
表明它要么是破骨细胞的前体,
再吸收细胞 输注时脾集落形成单位的形成
辐射大鼠和表型调制显示,这种细胞时,
在三维胶原晶格上生长的细胞进一步表明,
破骨细胞"干细胞"。 本研究提案的总体目标
是确定它是否是破骨细胞谱系中的细胞,
表征FM-2细胞系的骨细胞特性,
定义允许这些最大表达的条件
破骨细胞样特性。
实验方案被设计为:1)识别和优化
培养和基质条件是分化的关键
FM-2细胞系。 这将通过将细胞培养在
失活骨或类似骨的重组基质,或
一个孤立的体内系统,裸鼠的心房空间。 一
形态学和生物化学特征,以监测
线或新的子线将被开发,2)确定的影响,
在骨中有活性的激素(例如,甲状旁腺激素,降钙素,或
1,25(OH)2D3)和分化因子(例如,集落刺激因子,
OAF、5-氮杂胞苷、视黄酸)对细胞表型表达的影响
线,3)通过FM-2恢复小眼小鼠的骨重建功能
细胞移植物,4)分离并部分纯化骨吸收因子
使用羟基磷灰石色谱法。 部分纯化的因子将是
用于产生单克隆抗体,随后用于亲和层析
层析和生物学特性的研究。
这些研究将为骨的分化提供新的信息
体外吸收干细胞。 分化骨的建立
再吸收细胞可能被证明是有用的模式,为了解生物学和
破骨细胞和其他骨吸收细胞的生物化学。 这样的模型
也可用于研究骨丢失的机制,
生理和病理状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES F DUNN其他文献
JAMES F DUNN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES F DUNN', 18)}}的其他基金
CHARACTERIZATION OF A HUMAN OSTEOCLAST-LIKE CELL LINE
人类破骨细胞样细胞系的表征
- 批准号:
3154082 - 财政年份:1985
- 资助金额:
$ 8.11万 - 项目类别:
CHARACTERIZATION OF A HUMAN OSTEOCLAST-LIKE CELL LINE
人类破骨细胞样细胞系的表征
- 批准号:
3157307 - 财政年份:1985
- 资助金额:
$ 8.11万 - 项目类别:
DIURNAL CHANGES IN PLASMA BINDING OF ALDOSTERONE AND CORTISOL
醛固酮和皮质醇血浆结合的每日变化
- 批准号:
4704595 - 财政年份:
- 资助金额:
$ 8.11万 - 项目类别:
1,25-DIHYDROXYVITAMIN D LEVELS IN HEALTH AND DISEASE
1,25-二羟基维生素 D 水平与健康和疾病的关系
- 批准号:
4704596 - 财政年份:
- 资助金额:
$ 8.11万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 8.11万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 8.11万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 8.11万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 8.11万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 8.11万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 8.11万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 8.11万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 8.11万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 8.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 8.11万 - 项目类别:
Collaborative Research and Development Grants